ArticleFrontiers in nutrition2026
Italian style coffee consumption and metabolically dysfunctional-associated steatotic liver disease (MASLD): a cohort population study in Southern Italy.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of Coffee Consumption on Fructose-Related Metabolic Alterations: Potential Mechanisms and Implications for Metabolic Diseases.Diseases (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently the most prevalent chronic liver disease globally, and its incidence is rising consistently along with the prevalence of type 2 diabetes mellitus and overweight/obesity. Coffee has a unique chemical composition consisting of numerous compounds that contribute to metabolic and liver health. Nevertheless, it is not yet clear what dose of coffee should be safely consumed to positively impact MASLD. The current study aimed to examine the association between the consumption of Italian-style coffee in terms of cups per day, and the protection against MASLD within a cohort from southern Italy. The results indicated that the risk of developing MASLD decreased as daily coffee consumption increased when compared to consuming less than one cup per day (1 cup: 0.479 95% CI 0.244; 0.944; 2 cups: 0.468 95% CI 0.242; 0.905; 3 cups: 0.449 95% CI 0.225; 0.893), with the greatest benefit at 4-6 cups (OR: 0.407; 95% CI 0.186; 0.893). These findings suggest that moderate coffee consumption, specifically Italian-style coffee, may offer potential benefits due to its unique chemical composition and preparation method. This type of coffee may provide specific protective effects on liver and metabolic health. Given its cultural significance and positive metabolic attributes, Italian-style coffee has the potential to be recognized as a functional food for the prevention of MASLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.